ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2018 American Transplant Congress

    Impact of De Novo DSA Development and Management on Kidney Transplant Outcomes

    M. Cote,1 M. Pavlakis,2 F. Cardarelli,2 J. Pena,3 A. Dinh,3 K. Richards,1 K. Joyal,1 C. Rogers.1

    1Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA; 2Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA; 3Pathology, Beth Israel Deaconess Medical Center, Boston, MA.

    Multiple studies have shown that development of donor specific antibodies (DSAs) can have a negative impact on renal allograft outcomes resulting in decreased renal function,…
  • 2018 American Transplant Congress

    Noninvasive Quantization of Intra-Renal Allograft C4d Deposition with Targeted Ultrasound Imaging

    T. Liao,1 Y. Zhang,1 J. Ren,2 H. Zheng,1 H. Zhang,2 X. Liu,1 T. Yin,2 Q. Sun.1

    1Organ Transplantation Research Institute, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China; 2Department of Medical Ultrasound, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

    Antibody-mediated rejection (AMR) has emerged as the major cause of renal allograft dysfunction. C4d, a specific marker of AMR diagnosis, was strongly recommended for routine…
  • 2018 American Transplant Congress

    Anti-Angiotensin II Type 1-Receptor Antibodies (AT1R-Ab) Induce a Specific Phenotype of Rejection Distinct from HLA Antibody-Mediated Rejection

    C. Lefaucheur,1 D. Viglietti,1 O. Aubert,1 A. Philippe,2 P. Halloran,3 A. Loupy,1 D. Dragun.2

    1Paris Translational Research Center for Organ Transplantation, Paris, France; 2Medical Faculty of the Charité, Berlin, Germany; 3Alberta Transplant Applied Genomics Centre, Edmonton, Canada.

    AT1R-Ab have been associated with kidney allograft rejection; however, their ability to induce a specific rejection phenotype, independent of HLA-DSAs, has not been defined.In a…
  • 2018 American Transplant Congress

    Marijuana Use Should Not Preclude Consideration for Kidney Transplantation

    K. Fabbri, T. Anderson-Haag, A. Spenningsby, A. Israni, R. Nygaard, P. Stahler.

    Hennepin County Medical Center, Minneapolis, MN.

    Purpose: Policies for transplant eligibility for tobacco and marijuana (MJ) users vary among transplant centers. The aim of this study was to compare the impact…
  • 2018 American Transplant Congress

    RNA Expression Profiling of Renal Allografts in a Non-Human Primate Identifies Inflammation as a Risk Factor in Chronic Antibody Mediated Rejection

    R. Smith,1 B. Adam,2 A. Rosales,1 M. Matsunami,3 T. Oura,3 B. Cosimi,3 T. Kawai,3 M. Mengel,2 R. Colviin.1

    1Pathology, Massachusetts General Hospital, Boston, MA; 2Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada; 3Surgery, Massachusetts General Hospital, Boston, MA.

    IntroductionChronic alloantibody mediated rejection (CAMR) is a major risk factor in renal allografts. Some inflammation is commonly identified within CAMR, though mostly low grade, and…
  • 2018 American Transplant Congress

    Clinical Impact of Denovo or Recurrent Donor Specific Antibodies in the First Year Post Kidney Transplant in Patients on Early Steroid Withdrawal Immunosupression Regimen

    O. Adebiyi, T. Taber, W. Goggins, D. Mishler, M. Yaqub, A. Sharfuddin.

    Division of Renal Disease and Hypertension, Indiana University Health, Indianapolis, IN.

    Background: Immunologic risk monitoring of recipients of kidney transplant(Tx) using donor specific antibodies (DSA) has become a standard practice in most Tx centers in the…
  • 2018 American Transplant Congress

    The Results of the PRISM (Prediction of Rejection In Sensitized Patient Blood SaMples) Trial with a Novel Bioassay

    F. Vincenti, A. Schroeder, S.-C. Hseish, J. Liberto, P. Towfighi, C. Koh, T. Sigdel, M. Sarwal.

    Surgery and Medicine, University of California San Francisco, San Francisco.

    Background. kSORT, a 17 gene blood biomarker, has been retrospectively validated for detection of BPAR and immune quiescence in kidney tx. This is the first…
  • 2018 American Transplant Congress

    An Integrative Approach for the Assessment of Peritubular Capillaritis Extent and Score in Microvascular Inflammation – Association with Transplant Glomerulopathy and Graft Loss

    N. Kozakowski,1 H. Herkner,2 F. Eskandary,3 M. Eder,3 W. Winnicki,3 G. Bond,3 Ž. Kikić.3

    1Department of Pathology, Medical University of Vienna, Vienna, Austria; 2Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria; 3Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

    Background:Banff Classification accepts two histomorphological features as surrogates of HLA Antibody-Antigen interaction on renal endothelium: C4d staining and microvascular inflammation scores (MVI sum score:ptc+g≥2) which…
  • 2018 American Transplant Congress

    Comparison of Microvascular Inflammation in Renal Allograft Tissue between ABO Incompatible and ABO Compatible Kidney Transplantation

    E. Ko,1,2 B. Choi,1,2 C. Park,1,2 Y. Kim,1,2 C. Yang,1,2 B. Chung.1,2

    1Transplant Research Center, College of Medicine, Seoul St.Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea; 2Division of Nephrology, Department of Internal Medicine, College of Medicine, Seoul St.Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.

    Background: Microvascular inflammation (MVI) is considered as a pathological marker for antibody-mediated rejection (AMR) in the presence of donor-specific antibody (DSA). We aimed to investigate…
  • 2018 American Transplant Congress

    Impact of Vitamin D Status on Immune-Mediated Graft Function Following Kidney Transplantation

    C. Pham,1 B. Pierce,1 S. Bapat,2 S. Kuten,1 L. Moore,3 A. Gaber.3

    1Department of Pharmacy, Houston Methodist Hospital, Houston; 2College of Pharmacy, University of Houston, Houston; 3Department of Surgery, Houston Methodist Hospital, Houston.

    Ubiquitous expression of vitamin D receptors on antigen-presenting cells has sparked interest into its immunomodulatory effects. While previous literature has described the effect of vitamin…
  • « Previous Page
  • 1
  • …
  • 97
  • 98
  • 99
  • 100
  • 101
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences